Genetic mutations can alter protein behavior in various ways, including gaining new functions (neomorphs), increasing existing activity (hypermorphs), or decreasing physiological effects (hypomorphs). These researchers introduced PHNToM, a computational framework designed to classify variants of unknown functional significance (VUFS) by comparing their regulatory signatures to established mutations. By utilizing transcriptional activity networks and Gaussian mixture models, the tool identifies how specific mutations dysregulate downstream targets in a tumor-specific context. Experimental validation confirmed the method's accuracy, successfully identifying gain-of-function events in genes like FGFR2 and PIK3CA. The study also highlights how mutations in different genes can mimic one another or exhibit epistatic interactions that influence cancer development. Ultimately, this approach addresses the challenges of scaling functional assays to real-time clinical diagnostics for newly detected patient variants.

References:

• Tagore S, Tsang S, Tangermann C, et al. Pan-cancer inference and validation of hypermorphic, hypomorphic and neomorphic mutations[J]. Nature Genetics, 2026, 58(2): 329-340.

This research explores the complex interaction between genetics and environmental exposures by analyzing DNA methylation patterns in various human immune cells. Scientists examined how external factors, such as viral infections like COVID-19, bacterial encounters, and chemical exposures, trigger specific epigenetic modifications that alter gene expression. By using advanced single-cell sequencing technologies, the study identified unique cellular clusters and regulatory markers that distinguish healthy individuals from those affected by disease or toxins. The findings highlight that while many biological traits are inherited, environmental stressors significantly reshape the epigenome in a cell-type-specific manner. Ultimately, this work provides a detailed framework for understanding how nature and nurture combine to influence immune system functionality and disease susceptibility.

References:

• Wang W, Hariharan M, Ding W, et al. Genetics and environment distinctively shape the human immune cell epigenome[J]. Nature Genetics, 2026: 1-12.

The Human Retina Cell Atlas (HRCA) serves as a comprehensive multi-omic reference, integrating single-cell and single-nuclei RNA-sequencing with chromatin accessibility data to map the eye’s regulatory landscape. Researchers utilized this data to identify unique transcription factor combinations that define specific cell types, such as the newly distinguished BB and GB bipolar cells. The study also highlights significant evolutionary differences between mouse and primate retinal structures, noting that while many cell types correlate across species, some remain unique to humans. Beyond basic biology, the atlas tracks how gene expression changes with age, retinal location, and genetic ancestry, providing insights into varying immune responses. Finally, the HRCA offers a powerful tool for disease research, allowing scientists to fine-map genetic variants associated with conditions like glaucoma and inherited retinal degenerations. By linking specific cis-regulatory elements to target genes, the project establishes a foundation for understanding the mechanisms behind vision loss and potential therapeutic targets.

References:

• Li J, Wang J, Ibarra I L, et al. Single-cell atlas of the transcriptome and chromatin accessibility in the human retina[J]. Nature Genetics, 2026: 1-16.

This research study utilizes single-nucleus RNA sequencing and spatial transcriptomics to establish a biological framework for Chronic Obstructive Pulmonary Disease (COPD). By analyzing lung tissue and plasma, researchers identified that the disease is not a single entity but a collection of aberrant cell states, including specific shifts in epithelial, endothelial, and fibroblast populations. The findings show that as the disease progresses, cells responsible for gas exchange decline while inflammatory and remodeling cell types increase. The study also identifies protein biomarkers in the blood that correlate with these internal tissue changes, offering a potential method for noninvasive monitoring. Ultimately, this work provides a roadmap for precision medicine, allowing for better patient stratification and the development of targeted therapies based on a patient’s unique cellular profile.

References:

• Zhang Y, Wei H, Nouws J, et al. Aberrant cellular communities underlying disease heterogeneity in chronic obstructive pulmonary disease[J]. Nature Genetics, 2026: 1-16.

This research highlights the essential role of humoral immunity in determining the success of immune checkpoint blockade (ICB) therapy across various cancers, particularly hepatocellular carcinoma. The study identifies that patients who respond well to treatment exhibit a significant expansion of IgG1-secreting plasma cells and specialized B cell niches within the tumor environment. These beneficial immune cells produce antibodies targeting cancer-testis antigens, a process that appears to coordinate with T cell activity to enhance anti-tumor responses. In contrast, non-responders tend to accumulate dysfunctional or memory B cells within immunosuppressive stromal regions that hinder effective immunity. By analyzing diverse clinical datasets, the authors demonstrate that a high IgG1 genetic signature strongly correlates with improved survival rates following immunotherapy. These findings suggest that monitoring and therapeutically promoting B cell differentiation into IgG1 plasma cells could serve as a powerful strategy for improving patient outcomes.

References:

• Gonzalez-Kozlova E, Sweeney R, Figueiredo I, et al. Humoral IgG1 responses to tumor antigens underpin clinical outcomes in immune checkpoint blockade[J]. Nature Medicine, 2026: 1-14.

This research article investigates biomarkers and cellular ecosystems that influence how gastric cancer patients respond to perioperative immunotherapy and chemotherapy. By analyzing data from the NEOSUMMIT-01 clinical trial, the authors identified specific genetic factors, such as HLA-B and LRP1B mutations, that serve as predictors for treatment success. The study categorizes the tumor microenvironment into five distinct ecotypes, ranging from immune-active zones that favor recovery to immunosuppressive regions that resist therapy. A critical discovery involves APOA1+ tumor cells, which appear to drive resistance by signaling TREM2+ macrophages to adopt a suppressive state. These findings suggest that targeting these metabolic and immune interactions could improve the effectiveness of treatments for locally advanced gastric cancer.

References:

• Zhao Q, Huang R, Wang C, et al. Dissecting genetic and immune drivers of heterogeneous responses to neoadjuvant immunochemotherapy in gastric cancer[J]. Cancer Cell, 2026.

This research explores how exercise-induced blood factors, specifically the enzyme GPLD1, can combat brain aging and cognitive decline. The study identifies tissue-nonspecific alkaline phosphatase (TNAP) as a critical regulator of the blood-brain barrier, noting that excessive levels of this enzyme impair vascular integrity and memory. By increasing liver-derived GPLD1 or pharmacologically inhibiting TNAP, researchers were able to reverse age-related inflammatory signatures and improve learning in elderly mice. These interventions also showed promise in Alzheimer’s disease models, significantly reducing amyloid plaques and restoring cognitive function. Ultimately, the findings suggest that targeting these systemic pathways can rejuvenate the cerebrovascular system to protect against neurodegeneration. This work highlights a potent molecular mechanism through which physical activity maintains neurological health.

References:

• Bieri G, Pratt K J B, Fuseya Y, et al. Liver exerkine reverses aging-and Alzheimer’s-related memory loss via vasculature[J]. Cell, 2026.

Recent research examining the Y chromosome reveals that both inherited haplogroups and the somatic loss of the Y chromosome (LOY) significantly influence male health, particularly regarding Type 2 Diabetes (T2D). By analyzing large-scale data from East Asian and European biobanks, scientists identified that the Japanese-specific haplogroup D provides a protective effect against the development of LOY. While smoking and aging remain primary drivers of chromosome loss, this study highlights how LOY uniquely increases the risk of metabolic and respiratory diseases in East Asian populations. Single-cell sequencing further demonstrates that LOY disrupts gene regulatory networks in vital areas, such as pancreatic beta cells and immune cells. These findings suggest that incorporating sex-chromosome variations into genetic risk assessments can substantially improve the accuracy of disease prediction for both men and women. Ultimately, the work underscores the complex interplay between germline genetics, environmental factors, and somatic mutations in human biology.

References:

• Sato, G., Yamamoto, Y., Sonehara, K. et al. Genetic regulation across germline and somatic variation on the Y chromosome contributes to type 2 diabetes. Nat Med (2026). doi.org

This review by Douglas Hanahan synthesizes twenty-five years of research into the hallmarks of cancer, a conceptual framework used to organize the vast complexities of the disease. The author categorizes the mechanistic foundation of cancer into four distinct dimensions: acquired functional capabilities, enabling phenotypic characteristics, specialized cells within the tumor microenvironment, and systemic interactions. The updated model identifies nine hallmark capabilities, such as sustaining proliferative signaling and evading immune destruction, alongside five enabling traits like genomic instability and chronic inflammation. A significant focus is placed on the tumor microenvironment, where diverse cell types like fibroblasts, macrophages, and neurons are reprogrammed to support malignancy. Furthermore, the text explores how systemic factors like aging and obesity modulate these hallmarks, influencing how tumors develop and evolve. Ultimately, Hanahan proposes that therapeutic co-targeting—using drug combinations to disrupt multiple hallmarks simultaneously—could overcome adaptive resistance and significantly improve patient outcomes.

References:

• Hanahan D. Hallmarks of cancer—Then and now, and beyond[J]. Cell, 2026.

This research introduces histidine scanning as a versatile engineering strategy to improve the signaling strength of T cell receptors and other mechanosensory proteins. By replacing specific residues with histidine, the scientists identified hotspots that promote the formation of catch bonds, which are molecular interactions that strengthen when subjected to physical force. This method allows for the creation of low-affinity, high-potency TCRs that effectively kill tumor cells while avoiding the off-target toxicity often seen in traditional high-affinity therapies. The study demonstrates that this technique is not limited to immunology but can also modulate signaling in other systems, such as DLL4-Notch and Fc-FcR interactions. Ultimately, this approach provides a structural blueprint for designing more precise and powerful immunotherapies for solid tumors and blood cancers.

References:

• Wang Y, Wang Y, Yuan W, et al. Tuning the sensitivity of mechanosensory receptors through histidine scanning[J]. Cell, 2026.